• IGI Therapeutics SA

    NE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-645.4.097.189-3
    Sector: Research and development

    Age of the company

    21 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    322,5 Mio.

    Employees

    PremiumPremium

    Active brands

    0

    Reports for IGI Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About IGI Therapeutics SA

    • IGI Therapeutics SA has its legal headquarters in La Chaux-de-Fonds, is active and operates in the sector «Research and development».
    • The company was founded on 05.07.2004.
    • The last commercial register change was made on 17.07.2025. All changes can be viewed under the section «Notifications» and saved as a PDF.
    • The company's UID is CHE-111.750.689.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Acquisition, exploitation, vente et cession en licence de tous les biens relevant de la propriété intellectuelle et industrielle (brevets, marques, inventions, dessins, modèles); fabrication, directement ou par sous-traitance, de tous produits phamarmaceutiques; recherche et développement; accorder des prêts ou des garanties à des actionnaires ou des tiers, dans l'intérêt de la société.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Grant Thornton AG, succursale à Genève
    Genève 20.09.2017

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    PricewaterhouseCoopers SA
    Neuchâtel 09.07.2004 19.09.2017

    Other company names

    Source: SOGC

    Past and translated company names

    • IGI Therapeutics Ltd
    • IGI Therapeutics AG
    • Ichnos Sciences Ltd
    • Ichnos Sciences AG
    • Ichnos Sciences SA
    • Glenmark Pharmaceuticals AG
    • Glenmark Pharmaceuticals SA
    • Glenmark Pharmaceuticals Ltd
    Would you like to update the company name? Click here.

    Branches (1)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: IGI Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250717/2025 - 17.07.2025
    Categories: Change in management

    Publication number: HR02-1006387906, Commercial Registry Office Neuenburg, (645)

    IGI Therapeutics SA, à La Chaux-de-Fonds, CHE-111.750.689 (FOSC du 13.06.2025, p. 0/1006355708). Vaidyanathan Subramani n'est plus membre du conseil d'administration;
    ses pouvoirs sont radiés.

    SOGC 250613/2025 - 13.06.2025
    Categories: Miscellaneous changes

    Publication number: HR02-1006355708, Commercial Registry Office Neuenburg, (645)

    IGI Therapeutics SA, à La Chaux-de-Fonds, CHE-111.750.689 (FOSC du 03.06.2025, p. 0/1006347452). Inscription de la mention de l'existence d'une succursale à Epalinges (CHE-218.656.750).

    SOGC 250606/2025 - 06.06.2025
    Categories: Debt call to creditors

    Publication number: SR01-0000013601, Commercial Registry Office Neuenburg

    Rubrique: Autres appels aux créanciers relevant du droit des sociétés Sous-rubrique: Appel aux créanciers suite à une fusion selon la LFus Date de publication: SHAB 06.06.2025, Publication répétée: 04.06.2025, 05.06.2025 Visible par le public jusqu¿au: 06.06.2028 Numéro de publication: Entité de publication Fritz Stahl, Rue du Trésor 9, 2000 Neuchâtel Appel aux créanciers suite à une fusion selon la LFus IGI Biotherapeutics SA avec IGI Therapeutics SA

  • Publication Organisation transférante: IGI Biotherapeutics SA CHE-403.827.216 Route de la Corniche 5 1066 Epalinges Organisation reprenante: IGI Therapeutics SA CHE-111.750.689 chemin de la Combeta 5 2300 La Chaux-de-Fonds Publication de la fusion dans la FOSC: 03.06.2025 Remarques juridiques: Appel aux créanciers suite à une fusion (Art. 25 al. 2 LFus). Les créanciers des entités qui fusionnent peuvent, dans le délai imparti, produire leurs créances et exiger des sûretés de l'entité reprenante. Délai : 03.09.2025 (3 mois à compter de la date à laquelle la fusion déploie ses effets juridiques)
    Point de contact: IGI Therapeutics SA (IGI Therapeutics AG) (IGI Therapeutics Ltd) Chemin de la Combeta 5,
  • La Chaux-de-Fonds

  • Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm